Evidence map›Paper›PMID 41294604›Full record

ArticleGels (Basel, Switzerland)2025

Synthesis and Evaluation of Carbon Black-Containing Hydrogels for the Adsorption of 5-Fluorouracil.

Ritsuko Sekiguchi-Arai, Yoshiko Yamazaki, Takao Sato, Naoki Noma, Kengo Oka, Mitsunobu Iwasaki

Abstract read
In one paragraph

Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ritsuko Sekiguchi-AraiGraduate School of Science and Engineering, Kindai University, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.ORCID 0009-0007-4137-979X
Yoshiko YamazakiMedical Materials Laboratory, SEED Co., Ltd., 1030-7 Fukuro, Konosu, Saitama 3690131, Japan.
Takao SatoMedical Materials Laboratory, SEED Co., Ltd., 1030-7 Fukuro, Konosu, Saitama 3690131, Japan.
Naoki NomaDivision of Joint Research Center, Kindai University, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.
Kengo OkaDepartment of Applied Chemistry, Kindai University, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.ORCID 0000-0002-1800-8575
Mitsunobu IwasakiGraduate School of Science and Engineering, Kindai University, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The widely used anticancer drug 5-Fluorouracil (5-FU) may potentially elicit adverse side effects on the eyes. To address this problem, we aimed to synthesize hydrogels containing carbon black (CB), a porous material, for use as a 5-FU-adsorbent contact lens material. High-performance liquid chromatography revealed a direct correlation between the specific surface area of CB particles and 5-FU adsorption. CB particles with functional surface groups were characterized by superior dispersibility in monomer solutions, whereas the results of combustion ion chromatography indicated that 5-FU adsorption was higher for hydrogels with a higher water content and that the addition of CB to the hydrogel further enhanced the rate of 5-FU adsorption by 21%. In addition, 5-FU was strongly fixed within the CB-printed hydrogel matrix even after washing, with hydrophobic interactions with CB being established to be highly effective for binding 5-FU. Collectively, the findings of our study revealed that CB-printed hydrogel is a promising novel material for fabricating 5-FU-trapping contact lenses.

Indexed as

2-hydroxyethyl methacrylate5-fluorouraciladsorptioncarbon blackcontact lenshydrogel

Identifiers

PMID41294604
PMCPMC12652628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.